A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.

Acute myeloid leukemia (AML) remains incurable for the majority of patients. AML originates from a rare population of cells, termed leukemic stem cells (LSCs) or leukemia-initiating cells ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

Indeed, a subtype of AML -- acute promyelocytic leukemia (APL) -- is already treated this way using a pair of drugs (all-trans retinoic acid and arsenic trioxide) that shove APL cells down the ...